IOVA vs CDNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 08, 2026

IOVA

55.4
AI Score
VS
IOVA Wins

CDNA

46.9
AI Score

Investment Advisor Scores

IOVA

55score
Recommendation
HOLD

CDNA

47score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric IOVA CDNA Winner
Forward P/E 0 94.3396 Tie
PEG Ratio 0 -0.12 Tie
Revenue Growth 65.7% 52.2% IOVA
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 55.4/100 46.9/100 IOVA
Profit Margin -89.1% 24.2% CDNA
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

IOVA 1M: +45.1% · 3M: +78.6% CDNA 1M: +60.4% · 3M: +117.8%

Current Technical Phase

IOVA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.6% over 20 days), RSI 71

RSI (14): 70.8 · Price: $6.34

CDNA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (30.1% over 20 days), RSI 73

RSI (14): 73.1 · Price: $46.69

Fundamentals Snapshot

Metric IOVA CDNA
Market Cap
Forward P/E -23.6 34.5
Trailing P/E 21.9
Revenue (TTM)
Revenue Growth 0.7% 0.5%
Gross Margin 0.5% 0.7%
Operating Margin -0.5% 0.0%
EPS -0.69 2.05
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, IOVA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.